...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Message: Insider Selling

RVXOT it is up to everyone to discuss what they wish. Thanks for that! Its exactly what I am doing as well, so why make a comment about me doing, what you just said everyone else has the right to do? Am I somehow different from others on the board?  The same questions get asked over and over again and the same answers are given over and over again. Thought redundancy on the board was a violation. Anyways,  ya the new timeline is yet another surprise. 

New Message
Please login to post a reply